![HelixTalk - Rosalind Franklin University's College of Pharmacy Podcast artwork](https://is1-ssl.mzstatic.com/image/thumb/Podcasts113/v4/89/d0/1c/89d01c4e-f16a-b250-50ec-8e5cfee21d11/mza_3581079248703134654.png/100x100bb.jpg)
076 - The New Move: Treating Tardive Dyskinesia
HelixTalk - Rosalind Franklin University's College of Pharmacy Podcast
English - April 03, 2018 10:00 - 36 minutes - 38 MB - ★★★★★ - 549 ratingsMedicine Health & Fitness Education drugs medicine rosalindfranklin medications pharmacist pharmacy pharmd rfums Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed
In this episode, we discuss two new agents (valbenazine and deutetrabenazine) -- the first of their kind to receive FDA approval to manage tardive dyskinesia most commonly associated with antipsychotic use.